Successfully controlling malaria in South Africa

South African Medical Journal

Volumn 104, Issue 3, 2014, Pages 224-227

  Blumberg, L ^a,b   Frean, J ^a,b   Moonasar, D ^c  

^a NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c NATIONAL DEPARTMENT OF HEALTH   (South Africa)

Author keywords

Malaria; Millenium development goals

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ; ARTESUNATE; CHLOROQUINE; DOXYCYCLINE; PYRIMETHAMINE PLUS SULFADOXINE; QUININE;

ANOPHELES ARABIENSIS; ANOPHELES FUNESTUS; ANTIMALARIAL DRUG RESISTANCE; ARTICLE; DISEASE SURVEILLANCE; HUMAN; INCIDENCE; INSECTICIDE RESISTANCE; MALARIA; MALARIA RAPID TEST; PARASITE TRANSMISSION; PLASMODIUM; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; VECTOR CONTROL;

ANIMALS; ANTIMALARIALS; CASE MANAGEMENT; COMMUNICABLE DISEASE CONTROL; DISEASE ERADICATION; HEALTH POLICY; HUMANS; MALARIA; MOSQUITO CONTROL; POLITICS; POPULATION SURVEILLANCE; SOUTH AFRICA;

EID: 84894705733     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: 10.7196/SAMJ.7600     Document Type: Article

References (46)

1. World Health Organization. Malaria Elimination: A Field Manual for Low and Moderate Endemic Countries. Geneva: WHO, 2007. http://www.who.int/iris/handle/10665/43796 (accessed 20 January 2014).
2. World Health Organization. World Malaria Report: 2012. Geneva: WHO, 2012. http://www.who.int/iris/handle/10665/78945 (accessed 20 January 2014).
3. World Health Organization. The Abuja Declaration and the Plan of Action. Geneva: WHO, 2003. http://www.rollbackmalaria.org/docs/abuja_declaration.pdf (accessed 20 January 2014).
4. World Health Organization. Millenium Development Goals. Geneva: WHO, 2000. http://www.who.int/topics/millennium_development_goals/about/en/ (accessed 20 January 2014).
5. African Union Secretariat. Fight Malaria: Africa Goes From Control to Elimination by 2010. 3rd Sesssion of the AU Conference of Ministers of Health, Johannesburg, 2007. http://www.aidswatchafrica.org/sites/default/files/publication-documents/AU_Malaria_Camapign.pdf (accessed 20 January 2014).
6. SADC Secretariat. Malaria Elimination. http://tis.sadc.int/english/sarn/elimination-eight-e8/ (accessed 20 January 2014).
7. Sharp BL, Kleinschmidt I, Streat E, et al. Seven years of regional malaria control collaboration-Mozambique, South Africa, and Swaziland. Am J Trop Med Hyg 2007;76(1):42-47.
8. South African Medical Research Council. Annual Report 2010/2011. http://www.mrc.ac.za/annualreport/annualreport1011.pdf (accessed 20 January 2014).
9. National Department of Health. Malaria Elimination Strategy for South Africa 2012-18. Pretoria: NDoH, 2012.
10. Coetzee M, Hunt RH. Malaria at its southern-most fringe in Africa. Research and Reviews in Parasitology 1998;58(3/4):175-179.
11. World Health Organization. Global Insecticide Use for Vector-borne Disease Control. Geneva: WHO, 2011. http://www.who.int/iris/handle/10665/44670 (accessed 11 August 2013).
12. Pluess B, Tanser FC, Lengeler C, Sharp BL. Indoor residual spraying for preventing malaria. Cochrane Database Syst Rev 2010;(4):CD006657. [http://dx.doi.org/10.1002/14651858.CD006657.pub2]
13. Govere JM, Durrheim DM, Kunene S. Malaria trends in South Africa and Swaziland and the introduction of synthetic pyrethroids to replace DDT for malaria control. S Afr J Sci 2002;98(1-2):19-21.
14. Coetzee M. Malaria and dengue vector biology and control in southern and eastern Africa. In: Knols BGJ, Louis C, eds. Bridging Laboratory and Field Research for Genetic Control of Disease Vectors. Wageningen: UR Frontis Series No. 11, 2005:101-109. [http://dx.doi.org/10.1007/1-4020-3799-6_9]
15. N'Guessan R, Corbel V, Akogbéto M, Rowland M. Reduced efficacy of insecticide-treated nets and indoor residual spraying for malaria control in pyrethroid resistance area, Benin. Emerg Infect Dis 2007;13(2):199-206. [http://dx.doi.org/10.3201/eid1302.060631]
16. Ranson H, N'guessan R, Lines J, Moiroux N, Nkuni Z, Corbel V. Pyrethroid resistance in African anopheline mosquitoes: What are the implications for malaria control? Trends Parasitol 2011;27(2):91-98. [http://dx.doi.org/10.1016/j.pt.2010.08.004]
17. Takken W, Knols BG. Malaria vector control: Current and future strategies. Trends Parasitol 2009;25(3):101-104. [http://dx.doi.org/10.1016/j.pt.2008.12.002]
18. World Health Organization. Global Strategic Framework for Integrated Vector Management. Document WHO/CDS/CPE/PVC/2004.10. Geneva: WHO, 2004. http://www.who.int/iris/handle/10665/68624 (accessed 11 August 2013).
19. Chanda E, Masaninga F, Coleman M, et al. Integrated vector management: The Zambian experience. Malar J 2008;7:164. [http://dx.doi.org/10.1186/1475-2875-7-164]
20. Zikusooka CM, McIntyre D, Barnes KI. Should countries implementing an artemisinin-based combination malaria treatment policy also introduce rapid diagnostic tests? Malar J 2008;7:176. [http://dx.doi.org/10.1186/1475-2875-7-176]
21. Gitonga CW, Kihara JH, Njenga SM, et al. Use of rapid diagnostic tests in malaria school surveys in Kenya: Does their under-performance matter for planning malaria control? Am J Trop Med Hyg 2012;87(6):1004-1011. [http://dx.doi.org/10.4269/ajtmh.2012.12-0215]
22. Moonasar D, Goga AE, Frean J, Kruger P, Chandramohan D. An exploratory study of factors that affect the performance and usage of rapid diagnostic tests for malaria in the Limpopo Province, South Africa. Malar J 2007;6:74. [http://dx.doi.org/10.1186/1475-2875-6-74]
23. Barnes KI, Durrheim DN, Little F, et al. Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa. PLoS Med 2005;2(11):e330. [http://dx.doi.org/10.1371/journal.pmed.0020330]
24. Shillcutt S, Morel C, Goodman C, et al. Cost-effectiveness of malaria diagnostic methods in sub-Saharan Africa in an era of combination therapy. Bull World Health Organ 2007;86(2):101-110. [http://dx.doi.org/10.2471/BLT.07.042259]
25. malERA Consultative Group on Diagnosis and Diagnostics. A research agenda for malaria eradication: Diagnoses and diagnostics. PLoS Med 2011;8(1):e1000396. [http://dx.doi.org/10.1371/journal.pmed.1000396]
26. Rheeder JC, Targett GA, Shanks D, Greenwood B. Killing the Parasite. San Francisco: Global Health Group, 2009:13.
27. McMorrow ML, Aidoo M, Kachur SP. Malaria rapid diagnostic tests in elimination settings-can they find the last parasite? Clin Microbiol Infect 2011;17(11):1624-1631. [http://dx.doi.org/10.1111/j.1469-0691.2011.03639.x]
28. Blumberg L, Frean J. Malaria control in South Africa-challenges and successes. S Afr Med J 2007;97(11):1193-1197.
29. National Department of Health. Guidelines for the Treatment of Malaria in South Africa. Pretoria: NDoH, 2010.
30. World Health Organization. Malaria Case Management Operations Manual. Geneva: WHO, 2009. http://www.who.int/iris/handle/10665/44124 (accessed 12 August 2013).
31. World Health Organization. Guidelines for the Treatment of Malaria. 2nd ed. Geneva: WHO, 2010. http://www.who.int/iris/handle/10665/44227 (accessed 12 August 2013).
32. Health Systems Trust. Bringing Health Closer to People: Local Government and the District Health System. Durban: Health Systems Trust, 2001. http://www.hst.org.za/all-publications (accessed 30 July 2013).
33. National Department of Health. White Paper for the Transformation of the Health System in South Africa. Pretoria: NDoH, 1997. http://www.doh.gov.za/index.php (accessed 30 July 2013).
34. Durrheim DN, la Grange JJ, Govere J, et al. Accuracy of a rapid immunochromatographic card test for Plasmodium falciparum in a malaria control programme in South Africa. Trans R Soc Trop Med Hyg 1998;92(1):32-33. [http://dx.doi.org/10.1016/S0035-9203(98)90944-0]
35. Moonasar D, Nuthulaganti T, Kruger PS, et al. Malaria control in South Africa 2000-2010: Beyond MDG6. Malar J 2012;11:294. [http://dx.doi.org/10.1186/1475-2875-11-294]
36. Achan J, Talisuna AO, Erhat A, et al. Quinine, an old anti-malarial drug in a modern world: Role in the treatment of malaria. Malar J 2011;10:144. [http://dx.doi.org/10.1186/1475-2875-10-144]
37. World Health Organization. Global Antimalarial Drug Policies Database-WHO African Region December 2012 Update. Geneva: WHO, 2012.
38. World Health Organization. Guidelines for the Treatment of Malaria. 2nd ed., rev. 1. Geneva: WHO, 2011.
39. Spencer-Jones JH. Malaria update. S Afr Med J 1996;86(6):622-624.
40. Soni PN, Gouws E. Severe and complicated malaria in KwaZulu-Natal. S Afr Med J 1996;86(6):653-656.
41. Durrheim DN, Frieremans S, Kruger P, et al. Confidential inquiry into malaria deaths. Bull World Health Organ 1999;77(3):263-266.
42. Mehta U, Durrheim DN, Blumberg L, et al. Malaria deaths as sentinel events to monitor healthcare delivery and antimalarial drug safety. Trop Med Int Health 2007;12(5):617-628. [http://dx.doi.org/10.1111/j.1365-3156.2007.01823.x]
43. Ukpe IS. Continuing medical education in unstable malaria areas. Bull World Health Organ 1999;77(11):948.
44. Stepniewska K, Ashley E, Lee SJ, et al. In vivo parasitological measures of artemisinin susceptibility. J Infect Dis 2010;201(4):570-579. [http://dx.doi.org/10.1086/650301]
45. World Health Organization. The Safety and Effectiveness of Single Dose Primaquine as a P. falciparum Gametocytocide. WHO Evidence Review Group. Geneva: WHO, 2012.
46. Beighton P, Botha MC. Inherited disorders in the black population of southern Africa. Part I. Historical and demographic background; genetic haematological conditions. S Afr Med J 1986;69(4):247-249.